 <h1>Droperidol Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to droperidol: injection solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Injection route (Solution)</p><p>Cases of QT prolongation and/or torsade de pointes, some fatal, have been reported in patients receiving droperidol at doses at or below recommended doses. All patients should undergo a 12-lead ECG prior to administration of droperidol to determine if a prolonged QT interval (i.e., QTc greater than 440 msec for males or 450 msec for females) is present. Do not administer droperidol if there is a prolonged QT interval. Droperidol is contraindicated in patients with known or suspected QT prolongation, including patients with congenital long QT syndrome. Administer droperidol with extreme caution to patients who may be at risk for development of prolonged QT syndrome, are over 65 years old, abuse alcohol, or when used concomitantly with benzodiazepines, volatile anesthetics, and IV opiates. ECG monitoring should be performed prior to treatment and continued for 2 to 3 hours after completing treatment to monitor for arrhythmias.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, droperidol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking droperidol:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>sweating</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Chills</li>
<li>cough</li>
<li>difficulty with breathing</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>noisy breathing</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>skin rash, hives, or itching</li>
<li>tightness in the chest</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Chest pain or discomfort</li>
<li>fainting</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>irregular or slow heart rate</li>
<li>low blood pressure or pulse</li>
<li>severe confusion or loss of consciousness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of droperidol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Anxiety</li>
<li>drowsiness</li>
<li>restlessness</li>
<li>trouble sitting still</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Difficulty with speaking</li>
<li>drooling</li>
<li>loss of balance control</li>
<li>muscle trembling, jerking, or stiffness</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>shuffling walk</li>
<li>stiffness of the limbs</li>
<li>twisting movements of the body</li>
<li>uncontrolled movements, especially of the face, neck, and back</li>
</ul><p>
<!-- end injection solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to droperidol: compounding powder, injectable solution</i></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Hypotension, irregular cardiac rhythm, mild or moderate tachycardia, QT prolongation, serious arrhythmias (e.g., torsades de pointes), ventricular tachycardia, cardiac arrest, death (some of these side effects occurred in patients with no known risk factors, and some were associated with droperidol doses at or below recommended doses)<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Unexplained fever, alteration of consciousness, extrapyramidal dysfunction, autonomic instability and elevated creatine kinase are all symptoms associated with neuroleptic agents.  If these symptoms develop in patients receiving droperidol therapy, immediate discontinuation of the drug is warranted.</p>
<p></p>
<p>Extrapyramidal symptoms such as acute dystonia, parkinsonism, akathisia, and oculogyric crisis have been reported in patients receiving droperidol in doses as low as 0.65 mg.  In addition, cases of akathisia have been reported in patients during epidural anesthesia.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Dysphoria, drowsiness, restlessness, hyperactivity, anxiety, hallucinations, dizziness, extrapyramidal symptoms, neuroleptic malignant syndrome, confusion, nervousness, paresthesia, somnolence, tremor, akathisia, oculogyric crisis, unexplained fever, alteration of consciousness, autonomic instability<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: pharyngitis, rhinitis, bronchospasm, laryngospasm (reported as rare)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylaxis (uncommon)<sup>[Ref]</sup></p><h3>Local</h3><p>Frequency not reported : Injection site pain<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Chills and/or shivering, tongue-swelling, sweating<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Inapsine (droperidol)." Janssen Pharmaceutica, Titusville, NJ. </p><p id="ref_2">2. Vice President,  Medical Affairs and Worldwide Drug Safety "Important drug warning letter. Available from: URL: http://www.fda.gov/medwatch/SAFETY/2001/inapsine.htm."   ([2001 Dec 4]):</p><p id="ref_3">3. Miyai N,  Kawasaki T,  Sugihara H,  Kayo R "Coronary artery spasm as a cause of droperidol-induced ventricular fibrillation." Anesth Analg 103 (2006): 1602-3</p><p id="ref_4">4. "Product Information. Droperidol (droperidol)." Abbott Pharmaceutical, Abbott Park, IL. </p><p id="ref_5">5. Merridew GC, Keefe PA "Presence of extrapyramidal side-effects from droperidol in low dose." Anaesth Intensive Care 22 (1994): 319-20</p><p id="ref_6">6. Szuba MP, Bergman KS, Baxter LR Jr, Guze BH, Reynolds CA, Pelletier LR "Safety and efficacy of high-dose droperidol in agitated patients." J Clin Psychopharmacol 12 (1992): 144-6</p><p id="ref_7">7. Patton CM Jr. "Rapid induction of acute dyskinesia by droperidol." Anesthesiology 43 (1975): 126-7</p><p id="ref_8">8. Ward NG "Akathisia associated with droperidol during epidural anesthesia." Anesthesiology 71 (1989): 786-7</p><p id="ref_9">9. Chambers RA, Druss BG "Droperidol: Efficacy and side effects in psychiatric emergencies." J Clin Psychiatry 60 (1999): 664-7</p><p id="ref_10">10. Melnick BM "Extrapyramidal reactions to low-dose droperidol." Anesthesiology 69 (1988): 424-6</p><p id="ref_11">11. Athanassiadis C, Karamanis A "Akathisia after long-term epidural use of droperidol: a case report." Pain 50 (1992): 203-4</p><p id="ref_12">12. Silberstein SD,  Young WB,  Mendizabal JE,  Rothrock JF,  Alam AS "Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial." Neurology 60 (2003): 315-21</p><p id="ref_13">13. Holmes VF, Adams F, Fernandez F "Respiratory dyskinesia due to antiemetic therapy in a cancer patient." Cancer Treat Rep 71 (1987): 415-6</p><p id="ref_14">14. Arrowsmith J, Gams RA "Dystonia with droperidol therapy." N Engl J Med 305 (1981): 227</p><p id="ref_15">15. Foster PN, Stickle BR, Laurence AS "Akathisia following low-dose droperidol for antiemesis in day-case patients." Anaesthesia 51 (1996): 491-4</p><p id="ref_16">16. Patel P, Bristow G "Postoperative neuroleptic malignant syndrome. A case report." Can J Anaesth 34 (1987): 515-8</p><p id="ref_17">17. Ratan DA, Smith AH "Neuroleptic malignant syndrome secondary to droperidol." Biol Psychiatry 34 (1993): 421-2</p><p id="ref_18">18. Bamrah JS "Neuroleptic-induced pyrexia. A benign variant." J Nerv Ment Dis 176 (1988): 741-3</p><p id="ref_19">19. Clark RJ "Tongue-swelling with droperidol." Anaesth Intensive Care 21 (1993): 898</p></div>
<div class="more-resources" id="moreResources">
<h2>More about droperidol</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>5 Reviews</li>
<li>Drug class: miscellaneous central nervous system agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Droperidol Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Inapsine</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Nausea/Vomiting</li>
<li>Nausea/Vomiting, Postoperative</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to droperidol: compounding powder, injectable solution</i></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Hypotension, irregular cardiac rhythm, mild or moderate tachycardia, QT prolongation, serious arrhythmias (e.g., torsades de pointes), ventricular tachycardia, cardiac arrest, death (some of these side effects occurred in patients with no known risk factors, and some were associated with droperidol doses at or below recommended doses)<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Unexplained fever, alteration of consciousness, extrapyramidal dysfunction, autonomic instability and elevated creatine kinase are all symptoms associated with neuroleptic agents.  If these symptoms develop in patients receiving droperidol therapy, immediate discontinuation of the drug is warranted.</p><p></p><p>Extrapyramidal symptoms such as acute dystonia, parkinsonism, akathisia, and oculogyric crisis have been reported in patients receiving droperidol in doses as low as 0.65 mg.  In addition, cases of akathisia have been reported in patients during epidural anesthesia.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Dysphoria, drowsiness, restlessness, hyperactivity, anxiety, hallucinations, dizziness, extrapyramidal symptoms, neuroleptic malignant syndrome, confusion, nervousness, paresthesia, somnolence, tremor, akathisia, oculogyric crisis, unexplained fever, alteration of consciousness, autonomic instability<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: pharyngitis, rhinitis, bronchospasm, laryngospasm (reported as rare)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylaxis (uncommon)<sup>[Ref]</sup></p><h3>Local</h3><p>Frequency not reported : Injection site pain<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Chills and/or shivering, tongue-swelling, sweating<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Inapsine (droperidol)." Janssen Pharmaceutica, Titusville, NJ. </p><p id="ref_2">2. Vice President,  Medical Affairs and Worldwide Drug Safety "Important drug warning letter. Available from: URL: http://www.fda.gov/medwatch/SAFETY/2001/inapsine.htm."   ([2001 Dec 4]):</p><p id="ref_3">3. Miyai N,  Kawasaki T,  Sugihara H,  Kayo R "Coronary artery spasm as a cause of droperidol-induced ventricular fibrillation." Anesth Analg 103 (2006): 1602-3</p><p id="ref_4">4. "Product Information. Droperidol (droperidol)." Abbott Pharmaceutical, Abbott Park, IL. </p><p id="ref_5">5. Merridew GC, Keefe PA "Presence of extrapyramidal side-effects from droperidol in low dose." Anaesth Intensive Care 22 (1994): 319-20</p><p id="ref_6">6. Szuba MP, Bergman KS, Baxter LR Jr, Guze BH, Reynolds CA, Pelletier LR "Safety and efficacy of high-dose droperidol in agitated patients." J Clin Psychopharmacol 12 (1992): 144-6</p><p id="ref_7">7. Patton CM Jr. "Rapid induction of acute dyskinesia by droperidol." Anesthesiology 43 (1975): 126-7</p><p id="ref_8">8. Ward NG "Akathisia associated with droperidol during epidural anesthesia." Anesthesiology 71 (1989): 786-7</p><p id="ref_9">9. Chambers RA, Druss BG "Droperidol: Efficacy and side effects in psychiatric emergencies." J Clin Psychiatry 60 (1999): 664-7</p><p id="ref_10">10. Melnick BM "Extrapyramidal reactions to low-dose droperidol." Anesthesiology 69 (1988): 424-6</p><p id="ref_11">11. Athanassiadis C, Karamanis A "Akathisia after long-term epidural use of droperidol: a case report." Pain 50 (1992): 203-4</p><p id="ref_12">12. Silberstein SD,  Young WB,  Mendizabal JE,  Rothrock JF,  Alam AS "Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial." Neurology 60 (2003): 315-21</p><p id="ref_13">13. Holmes VF, Adams F, Fernandez F "Respiratory dyskinesia due to antiemetic therapy in a cancer patient." Cancer Treat Rep 71 (1987): 415-6</p><p id="ref_14">14. Arrowsmith J, Gams RA "Dystonia with droperidol therapy." N Engl J Med 305 (1981): 227</p><p id="ref_15">15. Foster PN, Stickle BR, Laurence AS "Akathisia following low-dose droperidol for antiemesis in day-case patients." Anaesthesia 51 (1996): 491-4</p><p id="ref_16">16. Patel P, Bristow G "Postoperative neuroleptic malignant syndrome. A case report." Can J Anaesth 34 (1987): 515-8</p><p id="ref_17">17. Ratan DA, Smith AH "Neuroleptic malignant syndrome secondary to droperidol." Biol Psychiatry 34 (1993): 421-2</p><p id="ref_18">18. Bamrah JS "Neuroleptic-induced pyrexia. A benign variant." J Nerv Ment Dis 176 (1988): 741-3</p><p id="ref_19">19. Clark RJ "Tongue-swelling with droperidol." Anaesth Intensive Care 21 (1993): 898</p><h2>More about droperidol</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>5 Reviews</li>
<li>Drug class: miscellaneous central nervous system agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Droperidol Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Nausea/Vomiting</li>
<li>Nausea/Vomiting, Postoperative</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>